Civil Plaintiff
An Appeals Court Considers Paving the Way for a Multi-Billion Dollar Purdue Pharma Settlement Deal
A settlement that would allow Purdue Pharma to exit bankruptcy and require its owners to contribute billions of dollars to help combat the opioid crisis in the U.S. hinges on a legal question before a federal appellate panel on Friday.
Lawyers for the company, state and local governments, individual opioid victims and others who would receive payments under the deal will make their case before the 2nd Circuit U.S. Court of Appeals in New York City.
At issue is whether a bankruptcy court judge has the authority to grant members of the Sackler family who own the OxyContin maker protection from civil lawsuits over the toll of opioids. Family members have insisted on the legal shield in exchange for providing the money behind the settlement.
